chevron_leftBack
As of 24 April 2025, HLB Co., Ltd. has a market cap of $5.14B USD, ranking #2784 globally and #56 in South Korea. It ranks #245 in the Healthcare sector, and #50 in the Biotechnology industry.
Key Stats
Market Cap
$5.14BUSD
7.33T KRW
Enterprise Value
$5.23BUSD
7.47T KRW
Revenue (TTM)
$47.73MUSD
68.13B KRW
EBITDA (TTM)
-$78.77MUSD
-112.44B KRW
Net Income (TTM)
-$64.44MUSD
-91.98B KRW
EBITDA Margin
-165%
Profit Margin
-135%
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Biotechnology
CEO
Baek Yoon Ki
open_in_new
Employees
160
Founded
1975
Website
hlbbio.co.kr/
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 4.5% | 2.8% | 20% | -30% | -19% | -47% |
Upcoming Earnings
Earnings Date
Wed, May 14
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
028300
에이치엘비(주)
ISIN: KR7028300002
Shares Out.:
Shares Outstanding:
131.169M1
Shares Float:
117.465M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
55.9K KRW |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About HLB Co., Ltd.
HLB Co., Ltd. manufactures and constructs lifeboats and glass fiber pipes in South Korea and internationally. It engages in the repair and inspection of lifeboats; fabrication and installation of pipes; development and manufacturing of biopharmaceuticals products, such as anti-cancer drugs; and manufacture and sale of medical devices, as well as manufacture and sale of quasi-drugs products, including alcohol swabs, sampling tools, etc. The company is also involved in e-commerce, investment, and financing activities. HLB Co., Ltd. was founded in 1975 and is headquartered in Ulsan, South Korea.
